Professional membership and experienced mentor leadership offer new pharmacy technicians a dual advantage, serving as a comprehensive training accelerator.
|Articles|May 4, 2022
Daily OTC Pearl: Back and Body Pain Reliever
Author(s)Saro Arakelians, PharmD
Extra Strength Back & Body pain reliever treats minor body aches.
Advertisement
OTC/Lifestyle Pearl of the Day: OTC Back and Body Pain Reliever
Indication: Extra Strength Back & Body pain reliever treats minor body aches.
Insight:
- Aspirin 500 mg and caffeine 32.5.
- Coated caplets.
- Used for minor pains, back ache, and arthritis pain.
- Drink with full glass of water.
- Only for patients 12 years of age and older.
- Take 2 caplets every 6 hours, as needed.
- Do not exceed 8 caplets in 24 hours.
Source:
Advertisement
Related to this article
Artificial intelligence (AI) transforms a chaotic, reactive process into an adaptive, proactive system that improves workflow and patient safety.
New European Respiratory Society (ERS) update makes sotatercept a strong add-on recommendation, opening a fourth pathway for pharmacists to manage.
At the 2026 New England Institute of Ambulatory Care Pharmacists (NEIAP) Annual Forum, Jennifer Goldman detailed how monitoring data drive engagement—and how a new dual sensor readies pharmacists for ketone alerts.
With nearly 8 in 10 older adults misusing at least 1 OTC product, clearer counseling and labels could close the gap.
Contraceptive access gaps driven by federal rollbacks, provider shortages, and stalled state legislation could be narrowed by letting trained pharmacists prescribe birth control independently.
Cancer diagnoses among civilians exposed to 9/11 dust keep rising, with strained health programs struggling to meet growing needs.
With childhood immunization rates sliding and outbreaks accelerating, pharmacist-led counseling and vaccine administration can boost vaccination rates.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Adult Pneumococcal Immunizations: A Practical Guide for Pharmacists
2
FDA Approves Rebisufligene Etisparvovec as First Gene Therapy for Children With Sanfilippo Syndrome Type A
3
How Pharmacists Overcome PCSK9 Inhibitor Access Barriers
4
Finerenone Receives FDA Approval for Treatment of Adults With CKD Associated With T1D
5